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Abstract
Purpose To compare the characteristics and outcomes of
exit strategies following percutaneous nephrolithotomy
(PCNL) using the Clinical Research Office of the Endou-
rological Society (CROES) PCNL Global Study database.
Materials and methods Two matched data sets were
prepared in order to compare stent only versus NT only and
TTL versus NT only. Patients were matched on the exit
strategy using the following variables: case volume of the
center where they underwent PCNL, stone burden, the
presence of staghorn stone, size of sheath used at percu-
taneous access, the presence of bleeding during surgery,
and treatment success status. For categorical variables,
percentages were calculated and differences between the
four groups were tested by the chi-square test.
Results The only significant difference reported between
the matched pairs was between NT and stent only groups.
NT only PCNL was associated with significantly longer
operating times (p = 0.029) and longer hospital stay
(p \ 0.001) than stent only PCNL.
Conclusions Patients who undergo PCNL with less
invasive exit strategy involving a stent only have shorter
hospital stay than those who have postoperative NT. The
intraoperative course is the primary driver of complications
in PCNL and not necessarily the exit strategy.
Keywords Nephrostomy tube  Stent  PCNL  Tubeless 
Urinary stones
Introduction
Percutaneous nephrolithotomy (PCNL) is the recom-
mended treatment option for large or otherwise complex
renal or proximal ureteral stones [1]. The standard PCNL
procedure involves creating a narrow percutaneous access
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to the kidney and the formation of a working tract con-
necting the flank surface with the intrarenal collecting
system through which nephroscopy is performed. This
allows endoscopic stone disintegration and removal of the
stone fragments. A temporary nephrostomy tube (NT) is
usually left in place at the end of the procedure to allow
urinary drainage, tamponade of tract bleeding, and to
maintain access to the collecting system should delayed
‘‘second-look’’ nephroscopy be necessary.
The practice of routine NT placement is, however, open
to debate since 1997, when Bellman et al. [2] first dem-
onstrated that a ‘‘tubeless’’ PCNL, whereby the NT was
replaced by a double-J stent, was associated with less
postoperative pain, less analgesia requirement, shorter
hospital stay, and faster return to normal activities. Several
randomized controlled trials (RCTs) and their meta-anal-
yses [3, 4] suggest that the tubeless approach reduces
postoperative pain and hospital stay and that substituting
double-J stents with external ureteral catheters or no
drainage at all [totally tubeless (TTL)] further improves
patients’ compliance by eliminating stent-related symp-
toms and need for cystoscopic removal [5, 6]. On the other
hand, other well-designed RCTs demonstrate advantages of
early NT removal [7] or placement of small-bore NTs [8]
over the tubeless approach. As a consequence, the optimal
exit strategy after PCNL remains controversial.
The Clinical Research Office of the Endourological
Society (CROES) conducted a prospective observational
study collecting data of consecutive patients treated with
PCNL over a 1-year period at the 96 participating centers
around the world. The purpose of the CROES PCNL
Global Study was to establish a prospective global database
for the current indications and outcomes of PCNL. The
analysis of the database was intended to facilitate better
understanding of the fundamental differences between
clinical institutions around the world in the use of this
procedure and to identify specific factors that might influ-
ence treatment-related morbidity. The overall results for
indications, complications, and outcomes in the cohort of
over 5,800 patients treated at the centers participating in
the CROES PCNL Global Study have already been
reported [9, 10]. The present analysis aimed to provide a
photograph of worldwide clinical practice with PCNL exit
strategy and to compare the characteristics and outcomes of
the different exit strategies adopted by centers participating
at the CROES PCNL Global Study.
Materials and methods
The organization and methods of the CROES PCNL Global
Study have been described previously [9]. Patients were
treated with PCNL during a 1-year period between
November 2007 and December 2009. PCNL was carried
out either in the supine or in the prone position. Access to
the upper tract was guided by ultrasound and/or X-ray in
combination with retrograde intrarenal contrast injection.
Once access was obtained, a guidewire was inserted and
preferably maneuvered toward the ureter. Dilation was
performed with balloon, telescopic or serial dilators and an
Amplatz sheath was then positioned. The collecting system
was then inspected by nephroscope and the stones were
either disintegrated by laser, ultrasound or ballistic devices
or removed in toto with graspers. The procedure was
considered to have completed when all removable stones
had been taken out. Internal and/or and external
drain(s) were positioned according to the judgment of the
surgeon.
The need for transfusion was based on the clinical
judgment of the treating physician and local clinical
practice guidelines. Assessment of immediate stone
clearance was performed by ultrasound, X-ray or com-
puted tomography (CT) scanning, based on availability or
local clinical practice. Perioperative complications were
assessed and graded according to the modified Clavien
System [11] as applied to PCNL [12]. Patients’ charac-
teristics, surgical procedure and outcome data were ana-
lyzed according to the exit strategy, namely placement of
NT without ureteral stenting (NT only); ureteral stenting
without NT (stent only), and totally tubeless PCNL
(TTL).
Statistical analysis
Two matched data sets were prepared in order to compare
stent only versus NT only and TTL versus NT only. The
matched data sets were created using propensity score
matching, a multidimensional matching technique based
on multivariate logistic regression. Patients were matched
on the exit strategy using the following variables: case
volume of the center where they underwent PCNL, stone
burden, the presence of staghorn stone, size of sheath used
at percutaneous access, the presence of bleeding during
surgery, and treatment success status. These matching
factors were selected from a pool of preoperative char-
acteristics that would determine the surgeon’s choice for
exit strategy. For categorical variables, percentages were
calculated and differences between the four groups were
tested by the chi-square test with a level of significance of
p \ 0.05.
Contributions of individual investigators to the prepa-
ration of the manuscript and the significance of input in
data collection were considered in authorship allocation
according to the guidelines of CROES publications [13].
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Results
The characteristics of patients included in the matched pair
analysis are shown in Table 1. In all groups, there were
more males than females, patients were on average over-
weight, and the majority of patients had an American
Society of Anesthesiologists (ASA) score of 1 or 2. The
only significant difference between groups was that
patients who received a NT only were more likely to have
had previous open renal surgery than patients receiving a
stent only.
The distribution of patients according to the size of the
NT is shown in Fig. 1. Data were available for 5,046
patients. The most commonly sized NT used was a 20 Ch
(21.6 %) followed by a 14 Ch NT (16.4 %). In terms of
operative procedure, the only significant difference
between groups reported was between the NT and stent
only groups in regard to percutaneous access point. No
differences were observed between groups in stone-free
rates and the incidence of bleeding (Table 2). Mean dura-
tion of PCNL across treatment groups ranged from 67 to
82 min (Table 3). Mean operating time was significantly
longer for patients who had NT only compared with
patients who had ST only (p = 0.029). Postoperative hos-
pital stay was also significantly longer for NT only com-
pared with ST only patients (p \ 0.001). No other
significant differences between the two matched groups
were reported.
Discussion
In the past decade, there has been continuing interest in the
concept of foregoing NT placement after PCNL with the
intent of reducing some postoperative problems associated
with this policy, such as patient’s discomfort, urinary
leakage from the percutaneous tract, and prolonged hos-
pital stay. Based on several RCTs demonstrating efficacy
and safety of tubeless PCNL, such approach is currently
recommended in the European Association of Urology
guidelines [1] as a safe alternative to NT placement in
uncomplicated cases. Reasons for placing a NT at the end
Table 1 Patient characteristics according to exit procedure
NT only
n = 244
Stent only
n = 244
p value NT only
n = 68
TTL
n = 68
p value
Case volume [mean (SD)] 83.5 (66.1) 70.0 (59.5) 70.6 (48.9) 74.4 (59.7)
Gender no. (%)
Male 135 (55.6) 159 (65.2) 0.030 40 (58.8) 46 (67.6) 0.285
Female 108 (44.4) 159 (34.8) 28 (41.2) 22 (32.4)
Age (years) [mean (range)] 49.5 (14.7) 49.4 (15.3) 0.929 47.4 (14.9) 48.2 (14.5) 0.748
BMI [mean (SD)] 26.9 (4.8) 26.4 (4.8) 0.384 26.8 (5.1) 26.5 (3.7) 0.620
ASA physical status classification [no. (%)]
I 124 (51.0) 125 (53.6) 0.610 45 (68.2) 37 (55.2) 0.281
II 88 (36.2) 72 (30.9) 15 (22.7) 23 (34.3)
III 27 (11.1) 32 (13.7) 6 (9.1) 7 (10.4)
IV 4 (1.6) 4 (1.7) 0 (0.0) 0 (0.0)
Antiplatelet/coagulant therapy no. (%) 19 (7.8) 17 (7.0) 0.729 2 (2.9) 5 (7.4) 0.437
Previous open renal surgery no. (%) 20 (8.2) 8 (3.3) 0.020 4 (5.9) 4 (5.9) 0.715
Renal anomalies no. (%)
Ectopic 2 (0.8) 0 (0.0) 0.070 0 (0.0) 1 (1.5) 0.572
Horseshoe 9 (3.7) 2 (0.8) 1 (1.5) 1 (1.5)
Malrotation 3 (1.2) 5 (2.0) 1 (1.5) 0 (0.0)
Single kidney 9 (3.7) 3 (1.2) 0.143 1 (1.5) 1 (1.5) 1.000
Stone characteristicsa
Staghorn no. (%) 43 (17.6) 50 (20.5) 0.419 7 (10.3) 7 (10.3) 0.777
Multiple stones no. (%) 93 (38.1) 101 (44.4) 0.153 32 (52.9) 29 (57.4) 0.604
Single stone no. (%) 151 (61.9) 143 (58.6) 36 (47.1) 39 (42.6)
Stone size (mm3) [mean (SD)] 330.0 (228.6) 301.4 (214.8) 0.559 333.2 (189.7) 295.3 (186.7) 0.717
ASA American society of anesthesiologists, BMI body mass index, NT nephrostomy tube, TTL totally tubeless
a Analysis was done on complete data sets. Missing observations were excluded
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of PCNL include bleeding from the tract requiring tam-
ponade, keeping an access for a ‘‘second-look’’ procedure
when stone clearance is considered incomplete, and pro-
viding urinary drainage, though this could be achieved by a
ureteral catheter or a double-J stent.
Several RCTs and their meta-analyses [3, 4] have
shown that tubeless PCNL provides less postoperative
pain, less postoperative urinary leakage and shorter
hospital stay than NT placement. A report by Cormio
et al. on the use of TachoSil has been published
recently [14]. Results showed that compared with NT
placement, complication rates were lower, including
urinary leakage, and hospital stay was shorter. Pain and
analgesic use were similar with the two procedures. In
the present study, which provides a photograph of real-
life clinical practice worldwide, no differences were
reported between a matched pair analysis of tubeless
PCNL and stent only placement. The patients were
matched for clinical characteristics so removing any
selection bias. These findings remain interesting in view
of the fact that tubeless PCNL was applied also to some
‘‘complicated cases’’. Accordingly, TTL PCNL has been
shown to be safe and effective in cases of complex renal
stone disease [15, 16] and even in cases complicated
with hemorrhage [17]. Similarly, TTL PCNL has been
found to be safe and effective also in cases of moderate
to large stone burden [18], renal anomalies [19], and
elderly patients [20].
In the present study, operating time and postoperative
hospital stay were both significantly shorter for patients
receiving the less invasive stent only exit compared with
the more invasive NT. This observation remained valid
after matching the patient groups based on the patients’
characteristics that would predispose a surgeon to choose
one exit strategy instead of the other. Our results therefore
confirm that shorter hospital stay is indeed an advantage of
less invasive exit strategies.
This analysis did not reveal statistical differences in
complications between patients who received stents versus
NT or TTL versus NT recipients. This finding suggests that
the preoperative characteristics of the patients and the
clinical course of the surgery are the main drivers of
complication rate when considering the type of exit strat-
egy. Matched comparisons resulted into comparable groups
of patient with rather similar preoperative characteristics
and intraoperative course.
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Fig. 1 Distribution of patients according to the nephrostomy size
Table 2 Operative characteristics according to exit procedure
NT only
n = 244
Stent only
n = 244
p value NT only
n = 68
TTL
n = 68
p value
Position
Supine no. (%) 36 (14.8) 50 (20.5) 0.096 19 (27.9) 15 (22.1) 0.428
Prone no. (%) 208 (85.2) 194 (79.5) 49 (72.1) 53 (77.9)
Percutaneous access
Lower calyx no. (%) 171 (70.4) 129 (53.1) 0.001 61 (89.7) 50 (73.5) 0.080
Middle calyx no. (%) 39 (16.0) 63 (25.9) 6 (8.8) 12 (17.6)
Upper calyx no. (%) 19 (7.8) 47 (19.3) 1 (1.5) 5 (7.4)
Multiple calyces no. (%) 14 (5.8) 4 (1.6) 0 (0.0) 1 (1.5)
Tract dilation
Telescopic dilator no. (%) 119 (48.8) 135 (55.3) 0.147 21 (69.1) 28 (58.8) 0.211
Balloon dilator no. (%) 125 (51.2) 109 (44.7) 47 (30.9) 40 (41.2)
Postoperative stone-free rate no. (%) 213 (87.3) 217 (88.9) 0.575 62 (91.2) 62 (91.2) 1.00
Reported bleeding no. (%) 8 (3.3) 6 (2.5) 0.587 2 (2.9) 2 (2.9) 1.00
NT nephrostomy tube, TTL totally tubeless
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Conclusions
Patients who undergo PCNL with less invasive exit strat-
egy involving a stent only have shorter hospital stay than
those who have postoperative NT. The intraoperative
course is the primary driver of complications in PCNL and
not necessarily the exit strategy. Consequently, the choice
of exit strategy should be based on intraoperative course of
the PCNL.
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